Tag Archive for: AstronauTx

Hot topic: As the nights get shorter, are you getting enough sleep?

Sleep tends to come easy in winter. The nights are long, it’s cold, so what better place to be than bed? But as the days lengthen, we tend to awaken earlier – curtailing a decent night’s sleep.  It’s no trivial matter, as a good night’s sleep is essential to the health of our bodies and […]

AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team

Jane Rhodes appointed as Chief Executive Officer Magnus Ivarsson appointed as Chief Translation and Early Development Officer London UK, 1 October 2024 – AstronauTx Ltd (“AstronauTx”), a biotechnology company developing novel treatments for Alzheimer’s disease and other neurodegenerative disorders, today announces the appointment of Dr Jane Rhodes, PhD, MBA, as Chief Executive Officer (CEO) and member […]

Weekly wrap-up: Novo Holdings leads $105 million financing of Magenta Medical to support FDA approval for world’s smallest heart pump

Novo Holdings, a leading life science investor, on Tuesday announced that it has led a $105 million financing in Magenta Medical, developer of the Elevate™ System, the world’s smallest heart pump. The financing will be used to advance the company’s US clinical programs in multiple mechanical circulatory support (MCS) indications and to secure the first […]

AstronauTx and STORM recognised at inaugural One Nucleus Awards

Congratulations to our clients AstronauTx and STORM Therapeutics, which were recognised at the inaugural One Nucleus Awards in London in March.  AstronauTx scooped the Best Performing Primary R&D Company of the Year Award, while STORM won the One Nucleus Boston Bootcamp competition aimed at getting companies “US-ready”.  AstronauTx beat off strong competition to win the […]